Literature DB >> 1900941

Invariant chain promotes egress of poorly expressed, haplotype-mismatched class II major histocompatibility complex A alpha A beta dimers from the endoplasmic reticulum/cis-Golgi compartment.

C Layet1, R N Germain.   

Abstract

Invariant chain (Ii) is a nonpolymorphic, non-major histocompatibility complex (MHC)-encoded glycoprotein that rapidly associates with newly synthesized class II MHC alpha and beta chains in the rough endoplasmic reticulum. This oligomerization of Ii, alpha, and beta and their cotransport within the cell led to speculation that Ii was an essential alpha beta transport protein. However, direct tests failed to show an absolute requirement for Ii in class II MHC molecule transport. More recently, it has become clear that different class II alpha beta chain combinations vary greatly in their efficiency of cell-surface expression, based largely on the allelic origin of the alpha and beta amino-terminal regions. Because the previous tests of Ii for a role in class II molecule expression utilized efficiently expressed alpha beta combinations, we have reexamined this question with several haplotype-mismatched murine A alpha and A beta chain combinations of various potentials for cell-surface expression. Using a transient expression assay in Ii-negative COS cells, we find that many inefficiently expressed alpha beta combinations show marked augmentation of surface expression upon cosynthesis of Ii. This effect is absent or minimal with evolutionarily coselected, haplotype-matched chains that give efficient expression alone. Biochemical studies show that at least one component of the Ii effect is an increased egress of already formed alpha beta dimers from the rough endoplasmic reticulum/cis-Golgi. We suggest that these results reflect the interaction of Ii with the peptide-binding domain of the poorly expressed class II molecules, either aiding in maintenance of a transportable conformation or competing with endoplasmic reticulum retention proteins, and thus enhancing movement to the cell surface. These results suggest a complex and variable role for trans-associated alpha and beta chains in the immune responses of MHC heterozygotes and provide a method for examining Ii interaction with class II MHC molecules independent of measurement of peptide presentation to T cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1900941      PMCID: PMC51228          DOI: 10.1073/pnas.88.6.2346

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  Polypeptide chain binding proteins: catalysts of protein folding and related processes in cells.

Authors:  J E Rothman
Journal:  Cell       Date:  1989-11-17       Impact factor: 41.582

Review 2.  Immune response (Ir) genes of the murine major histocompatibility complex.

Authors:  R H Schwartz
Journal:  Adv Immunol       Date:  1986       Impact factor: 3.543

3.  Synthesis and expression of MHC class II molecules in the absence of attached invariant chains by recombinant-interferon-gamma-activated bone-marrow-derived macrophages.

Authors:  F J Schneider; B Opel; W Ballhausen; W Henkes; P Steinlein; K Reske
Journal:  Eur J Immunol       Date:  1987-09       Impact factor: 5.532

4.  Allele-specific control of Ia molecule surface expression and conformation: implications for a general model of Ia structure-function relationships.

Authors:  N S Braunstein; R N Germain
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

5.  The assignment of chain specificities for anti-Ia monoclonal antibodies using L cell transfectants.

Authors:  D Landias; B N Beck; J M Buerstedde; S Degraw; D Klein; N Koch; D Murphy; M Pierres; T Tada; K Yamamoto
Journal:  J Immunol       Date:  1986-11-01       Impact factor: 5.422

6.  Influence of allelic polymorphism on the assembly and surface expression of class II MHC (Ia) molecules.

Authors:  R N Germain; D M Bentley; H Quill
Journal:  Cell       Date:  1985-11       Impact factor: 41.582

7.  Structure-function analysis of the Abm12 beta mutation using site-directed mutagenesis and DNA-mediated gene transfer.

Authors:  F Ronchese; M A Brown; R N Germain
Journal:  J Immunol       Date:  1987-07-15       Impact factor: 5.422

8.  The role of the Ia-invariant chain complex in the posttranslational processing and transport of Ia and invariant chain glycoproteins.

Authors:  S Simonis; J Miller; S E Cullen
Journal:  J Immunol       Date:  1989-12-01       Impact factor: 5.422

9.  Regulation of murine MHC class II molecule expression. Identification of A beta residues responsible for allele-specific cell surface expression.

Authors:  J M Buerstedde; L R Pease; A E Nilson; M P Bell; C Chase; G Buerstedde; D J McKean
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

10.  Cell surface expression of class II histocompatibility antigens occurs in the absence of the invariant chain.

Authors:  R P Sekaly; C Tonnelle; M Strubin; B Mach; E O Long
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

View more
  35 in total

1.  Introducing endogenous antigens into the major histocompatibility complex (MHC) class II presentation pathway. Both Ii mediated inhibition and enhancement of endogenous peptide/MHC class II presentation require the same Ii domains.

Authors:  K Frauwirth; N Shastri
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

2.  Distinct binding sites on HLA-DR for invariant chain and staphylococcal enterotoxins.

Authors:  D R Karp; R N Jenkins; E O Long
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

3.  Secretion of a soluble, chimeric gamma delta T-cell receptor-immunoglobulin heterodimer.

Authors:  D Eilat; G E Kikuchi; J E Coligan; E M Shevach
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

4.  Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules.

Authors:  M S Anderson; J Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

Review 5.  Protein sorting within the MHC class II antigen-processing pathway.

Authors:  M S Marks
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

6.  Evidence that binding site occupancy is necessary and sufficient for effective major histocompatibility complex (MHC) class II transport through the secretory pathway redefines the primary function of class II-associated invariant chain peptides (CLIP).

Authors:  G Zhong; F Castellino; P Romagnoli; R N Germain
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

Review 7.  Endosomal localization of MHC class II-invariant chain complexes.

Authors:  J Miller
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

Review 8.  Physiological functions of endosomal proteolysis.

Authors:  T Berg; T Gjøen; O Bakke
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

9.  Truncation of the class II beta-chain cytoplasmic domain influences the level of class II/invariant chain-derived peptide complexes.

Authors:  S T Smiley; A Y Rudensky; L H Glimcher; M J Grusby
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

10.  Tubulation of class II MHC compartments is microtubule dependent and involves multiple endolysosomal membrane proteins in primary dendritic cells.

Authors:  Jatin M Vyas; You-Me Kim; Katerina Artavanis-Tsakonas; J Christopher Love; Annemarthe G Van der Veen; Hidde L Ploegh
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.